Participant characteristics of included studies. by Martha R. Smith (20410184)

“…This comprised seven studies comparing exercise intervention with non-exercising controls, three uncontrolled studies of exercise intervention, two studies comparing exercise plus lifestyle interventions with lifestyle interventions alone, and nine studies comparing different types of exercise interventions. Five of the 11 studies that evaluated hepatic steatosis reported an absolute decrease of 1% to 3%. …”

H₂O₂-treated <i>M</i>. <i>aeruginosa</i> forward scatter (FSC) and side scatter (SSC) relative to control. by Emma T. Brentjens (17295999)

Negative interactions between <i>yhp1-13A yox1-9A</i> and conditional alleles of target genes. by Michelle M. Conti (13514386)

<i>nt5e</i> confers Nt5e activity on <i>S. sanguinis</i> SK36 whole cells. by Jingyuan Fan (159998)

“…(A), (B), and (C) were showed as enzyme velocity vs. concentration of ATP, ADP and AMP substrates, where the results were represented as mean±SE, n = 3. …”

Reaction rate of G_olf affects <i>T</i>_1/2 only in the competitive model. by Hidetoshi Urakubo (578508)

ROBINS-I assessments. by Martha R. Smith (20410184)

2-butanone and tetrahydrofuran cause body shrinkage followed by relaxation. by Masahiro Tomioka (430683)

<i>M</i>. <i>aeruginosa</i> treatment chemicals and doses. by Emma T. Brentjens (17295999)

RoB 2 assessments. by Martha R. Smith (20410184)

SPIRIT schedule of enrolment, interventions, and assessments. by Rabia R. Chhangur (14828321)

Representative movie of tracking the nematodes moving on agar plates using the WormLab software. by Masahiro Tomioka (430683)

Correlation between the toxicity of ketones or cellosolves and their carbon number. by Masahiro Tomioka (430683)

ALKG1202R –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

ALKC1156Y –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

CCND1 promoted chemoresistance in CRC. by Dequan Wang (6007007)

ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

ALK^wt–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)